English

DECISIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ

Report this content 
BIOHIT OYJ        STOCK EXCHANGE RELEASE        21.4.2005


DECISIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ

The Annual General Meeting (AGM) of Biohit Oyj held on 21 April 2005 approved
unanimously the financial statements of the Biohit Group and the parent company,
and discharged the members of the Board of Directors and the president and CEO
from liability for the financial year 2004.

In accordance with the proposal by the Board of Directors the AGM decided
unanimously that no dividends be paid for the financial year 2004, and that the
loss of EUR 266,739.42 be transferred to the retained profit and loss account.
The AGM also decided unanimously to cover the loss by transferring EUR
266,739.42 from the share premium fund to the retained profit and loss account.

Members of the Board of Directors

The AGM decided unanimously that the number of the members of the Board of
Directors is six (6). Furthermore, the AGM elected Professor Reijo Luostarinen,
PhD Arto Alanko, Professor Mårten Wikström, LLM Peter Tchernych, Professor Osmo
Suovaniemi and Professor Hannu Seristö as members of the Board until the end of
the next AGM.

Moreover, the AGM decided unanimously that the chairman of the Board of
Directors would be paid a monthly fee of EUR 1,450 and the ordinary members would
be paid a monthly fee of EUR 1,100.

Auditors

The AGM re-elected authorized public accountants PricewaterhouseCoopers Oy as
the company’s auditors until the end of the next AGM. Furthermore, the AGM
decided that the auditors are to be paid on basis of the invoice issued.

Biohit Oyj

Board of Directors


Additional information:       Osmo Suovaniemi, President and CEO
                              Tel: 09-773 861, GSM: 040-745 5605
                              Email: osmo.suovaniemi@biohit.com
                              
Distribution:                 Helsinki Exchanges
                              Financial Supervisory Authority
                              Press
                              http://www.biohit.com

Subscribe